Built at Stanford, Acquired at Scale: Grove AI and the Next Generation of Clinical Trials + AI Agents

​Join us for a live demo and AMA with Tran Lê and Sohit Gatiganti, co-founders of Grove AI, a Stanford-founded startup that built the leading agentic AI platform for clinical trial operations, and was acquired by Hippocratic AI in January 2026.

​Founded in 2024 by former Stanford Medicine engineers, Grove AI developed Grace, an always-on AI agent that automates participant engagement, recruitment, and follow-up across voice, text, and email. In just one year, the platform powered more than 10 million patient interactions across 50+ Phase 2 and 3 clinical trials for some of the world's top pharmaceutical companies — all while raising a $4.9M seed round and partnering with two of the top five global pharma organizations.

​In January 2026, Grove was acquired by Hippocratic AI, the pioneer in patient-facing generative AI healthcare agents, where Grove's technology now forms a core pillar of their Life Sciences Division.

​Tran and Sohit will walk us through a live demo of the platform, share the full arc of the Grove journey, from Stanford beginnings to seed round to acquisition, and then open the floor to questions. Bring your questions about building in regulated spaces, agentic AI in clinical settings, and what the next chapter looks like inside Hippocratic AI.

​ Location: Edwards Building, Room 166 Thursday, February 26th | 4:30–5:50 PM

​This session is part of Evidence for Us: Reimagining Clinical Trials in the Digital Age (BIOS 297). We are opening select sessions to the broader Stanford community. Seats are extremely limited — please RSVP only if you are certain you can attend.